International Flavors & Fragrances Inc

International Flavors & Fragrances expands into Latin America and secures a key health‑claim approval in Australia/New Zealand, boosting its plant‑based, clean‑label portfolio and global reach.

International Flavors & Fragrances’ insider trades reveal regulatory transparency, modest holdings, and a resilient stock amid lower oil prices and sector rebound.

Executive equity transactions at IFF reveal insider confidence amid volatility, highlighting potential buy‑back signals and hidden risks for investors.

IFF expands Latin American enzyme production and innovation, boosting local fermentation in Argentina and creating a Brazil lab for faster, region‑specific solutions in health‑biosciences.

International Flavors & Fragrances launches a new Latin American enzyme hub, boosting regional health‑bioscience innovation, supply chain resilience, and ESG impact.

Discover why IFF’s earnings lag peers and how pivoting to natural, functional ingredients and stronger R&D could unlock value.

International Flavors & Fragrances launches a dividend reinvestment program, offering shareholders the chance to compound holdings while preserving capital for growth and R&D.

Explore IFF’s shift to high‑margin flavors, recent divestitures, and its future upside in a growing specialty‑ingredient market.

IFF’s decision to sell its Food Ingredients division signals a sharp pivot toward nutraceuticals and functional foods, reshaping the ingredient industry’s future.

International Flavors & Fragrances turns Q4 profit, outlines 2026 sales goals, and shares strategic moves for cost control and market resilience.